Lv6
1670 积分 2022-08-12 加入
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
2天前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
2天前
已完结
Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
5天前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
1个月前
已完结
Effect of albumin bolus therapy on vasopressor requirement after cardiac surgery
2个月前
已完结
20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study)
2个月前
已完结
Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice
2个月前
已完结
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
2个月前
已完结
Association of Postoperative Cumulative Fluid Balance and Outcomes Following Elective Cardiac Surgery
2个月前
已关闭
Albumin Infusion and Kidney Injury in Cardiac Surgery
2个月前
已完结
皖公网安备34019202002308
